University of California, Los Angeles

Breaking Forecast Boundaries: The California Annual Precipitation Report Delivers Water Year Clarity Beyond El Niño's Reach

Retrieved on: 
Tuesday, November 7, 2023
Environmental Issues, Environmental Health, Environment, Water, Temperature, ENSO, CAP, Bulletin, Data science, Multimedia, Public Policy Institute of California, California State Water Project, American Meteorological Society, Farmer, University, UCLA, Bulletin of the American Meteorological Society, Hydrology, National Weather Service, University of California, Los Angeles, Forecasting, Agriculture, Public policy, Rare-earth element, Management, Weather, Meteorology

Weather Tools, Inc. unveils the 2023-24 California Annual Precipitation (CAP) report today, emphasizing that water year precipitation is influenced by factors beyond El Niño alone.

Key Points: 
  • Weather Tools, Inc. unveils the 2023-24 California Annual Precipitation (CAP) report today, emphasizing that water year precipitation is influenced by factors beyond El Niño alone.
  • No other California water year precipitation forecast has come close to doing the same, making it the most accurate and reliable water year precipitation forecast in California.
  • While strong El Niño conditions are expected to persist into the spring of 2024, past El Niño events have shown significant variation in their impact on California precipitation.
  • In addition to the water year precipitation forecast, customers receive monthly progress reports with information on how the water year is unfolding.

AdvanCell Announces First Patient Dosed in Phase I/II TheraPb Clinical Trial of 212Pb-ADVC001 in Metastatic Prostate Cancer

Retrieved on: 
Tuesday, November 7, 2023
Science, Radiology, Biotechnology, Research, Pharmaceutical, Oncology, Health, Clinical Trials, Alpha particle, Prostate, Prostate cancer, MD, University of California, San Francisco, University, Peter MacCallum Cancer Centre, University of California, Los Angeles, Cancer, Targeted alpha-particle therapy, PSMA, Patient, Letter, Medical imaging, Pharmaceutical industry

“The first patient dosed with an AdvanCell therapeutic candidate represents a major milestone for the Company, our scientists, clinical trial sites, and our patients,” said Andrew Adamovich, CEO of AdvanCell.

Key Points: 
  • “The first patient dosed with an AdvanCell therapeutic candidate represents a major milestone for the Company, our scientists, clinical trial sites, and our patients,” said Andrew Adamovich, CEO of AdvanCell.
  • “We believe that 212Pb is the ideal radioisotope to realise the full therapeutic power of Targeted Alpha Therapy.
  • “We are excited to be moving this 212Pb-based therapy forward in the TheraPb clinical study.”
    Developed the world’s first 212Pb-based Targeted Alpha Therapy to enter clinical trials in metastatic prostate cancer.
  • Developed a proprietary target discovery and ligand development program encompassing a robust pipeline of Targeted Alpha Therapies to treat cancer.

Feinstein Institutes Awarded $6.1M to Fund Bipolar Disorder Patient and Research Hub

Retrieved on: 
Thursday, October 19, 2023
Mental Health, Health, Biometrics, Clinical Trials, Research, Science, Biotechnology, Knowledge, Patient, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Medical research, Feinstein, Feinstein Institutes for Medical Research, Transcranial magnetic stimulation, Johns Hopkins University, Zucker Hillside Hospital, Hofstra University, Psychiatry, Bipolar disorder, Multimedia, Donald, Clinical trial, Schizophrenia, Institutional review board, Behavioural sciences, Credit, University, Magnetic resonance imaging, University of California, Los Angeles, BD2, University of Michigan, Hospital, BSN, Mayo Clinic, Pharmaceutical industry, MD, Brigham, Wellcome

Approximately 2.3 million Americans live with bipolar disorder who are impacted by dramatic shifts in mood, energy and activity levels.

Key Points: 
  • Approximately 2.3 million Americans live with bipolar disorder who are impacted by dramatic shifts in mood, energy and activity levels.
  • Through a national research grant and innovative networking system aimed to connect patients to care, it might become easier for people with bipolar disorder to find new treatments and clinical trials.
  • (Credit: Feinstein Institutes)
    Researchers at The Feinstein Institutes for Medical Research received a $6.1 million grant from Breakthrough Discoveries for Thriving with Bipolar Disorders Foundation (BD2) to serve as a hub of six other sites across the country.
  • “Although bipolar disorder impacts millions of Americans every year, it is under-researched,” said Kevin J. Tracey, MD , president and CEO of the Feinstein Institutes and Karches Family Distinguished Chair in Medical Research.

Valentino Beauty and Her Campus Media Team Up For West Coast College Bus Tour

Retrieved on: 
Tuesday, October 10, 2023
Student, Gen, UCLA, University, Valentino, University of California, Los Angeles, Beauty, Assistant, Generation Z, Lip, Woman, Consumer activism, Video game

BOSTON, Oct. 10, 2023 /PRNewswire/ -- When brands want to reach and influence college students and Gen Z, they are turning to Her Campus Media, the #1 media portfolio for this important demographic. With that goal in mind, Valentino Beauty, a leading luxury beauty brand, is joining forces with Her Campus Media to expand Valentino Beauty's brand awareness and influence on West Coast campuses, with University of California at Los Angeles (UCLA) as the first stop on October 12 and 13, 2023.

Key Points: 
  • With that goal in mind, Valentino Beauty , a leading luxury beauty brand, is joining forces with Her Campus Media to expand Valentino Beauty's brand awareness and influence on West Coast campuses, with University of California at Los Angeles (UCLA) as the first stop on October 12 and 13, 2023.
  • "We view Her Campus Media as the unsurpassed leader when it comes to reaching Gen Z," says Nobles Crawford, Assistant Vice President of Consumer Activation, Luxury Beauty at Valentino Beauty.
  • This campus tour comes on the heels of a sampling program Her Campus Media powered for Valentino that resulted in over 400 reviews on Sephora.com for their new lip product, Liquirosso.
  • "The West Coast bus tour is so unique because it represents the first time Valentino Beauty will be interacting with Gen Z on their own turf - a college campus," continues Windsor Western.

BD² ANNOUNCES RESEARCH AND CLINICAL NETWORK TO ADVANCE TREATMENT FOR BIPOLAR DISORDER

Retrieved on: 
Wednesday, September 27, 2023
Partnership, Mayo Clinic, University, University of Michigan, Schizophrenia, Cone Health Women's Hospital, Cardiovascular disease, Research, Harvard Medical School, Attention, Bangladesh Technical Education Board, Doctor of Philosophy, Bipolar disorder, North East Local Health Integration Network, Discovery, Johns Hopkins University, MD, Patient, Milken Institute, Knowledge, Diagnosis, Hospital, University of California, Los Angeles, Health, Disease, Research fellow, Pharmaceutical industry, Psychology, Brigham, Psychiatry

WASHINGTON, Sept. 27, 2023 /PRNewswire/ -- BD²: Breakthrough Discoveries for Thriving with Bipolar Disorder today announced the first six institutions that will launch the groundbreaking BD² Integrated Network. Brigham and Women's Hospital-McLean Hospital, University of California Los Angeles, Johns Hopkins University, Mayo Clinic, University of Michigan, and UTHealth Houston together comprise the first sites that will work in partnership with clinicians, researchers, and people living with bipolar disorder to expand knowledge of bipolar disorder while accelerating the translation of that knowledge into clinical care. The BD² Integrated Network integrates clinical, behavioral, and biological data to gain new insight into bipolar disorder and accelerate improved treatment. Over the next five years, it will engage 4,000 people living with bipolar disorder as part of a longitudinal cohort study.

Key Points: 
  • The BD² Integrated Network integrates clinical, behavioral, and biological data to gain new insight into bipolar disorder and accelerate improved treatment.
  • Over the next five years, it will engage 4,000 people living with bipolar disorder as part of a longitudinal cohort study.
  • "For too long, there have been limited breakthroughs in the study and treatment of bipolar disorder," said Cara Altimus, PhD, managing director for BD² and senior director at the Milken Institute.
  • "Current understanding of the mechanisms of bipolar disorder are inadequate to meet the needs of individuals living with bipolar disorder today," said Mark Frye, MD, BD² Integrated Network scientific director.

Final Call for 2023 Biocodex Microbiota Foundation $50,000 U.S. Research Grant Applications

Retrieved on: 
Thursday, September 14, 2023
Human, University, Stanford University, Autism spectrum, DSM-IV codes, Research, Microbiota, Texas Children's Hospital, ASD, Michigan State University, Baylor College of Medicine, Hospital, University of California, Los Angeles, UCLA, Health, Disease, Medical device, Nursing, Pharmaceutical industry

BEDMINSTER, N.J., Sept. 14, 2023 /PRNewswire-PRWeb/ -- With the submission deadline approaching, the Biocodex Microbiota Foundation is announcing its last call for applications for their $50,000 research grant. The application can be downloaded online and is due by October 1, 2023.

Key Points: 
  • BEDMINSTER, N.J., Sept. 14, 2023 /PRNewswire-PRWeb/ -- With the submission deadline approaching, the Biocodex Microbiota Foundation is announcing its last call for applications for their $50,000 research grant.
  • Other previous Biocodex Microbiota Foundation $50,000 grant recipients include:
    The Biocodex Microbiota Foundation's annual call for grant applications is part of a multi-year research initiative to understand the interaction between microbiota and different pathologies.
  • Late or incomplete applications, or those that don't meet the criteria of the grant program or research topic, will not be considered.
  • To learn more information about Biocodex Microbiota Foundation and the 2023 US grant program, visit here .

Angeles Equity Partners Adds Brandon Gold to Operations Team

Retrieved on: 
Thursday, September 7, 2023
Consulting, Professional Services, Finance, Boston Consulting Group, University, PepsiCo, Vista Equity Partners, University of California, Los Angeles, MBA, Boston, Business administration, Gold, Engineering, SpaceX, Chemical engineering, Master of Business Administration, Financial services, Management, Science

Angeles Equity Partners, LLC (“Angeles”), a private investment firm focused on value creation through operational transformation, has appointed Brandon Gold as vice president, Operations for Angeles Operations Group, LLC.

Key Points: 
  • Angeles Equity Partners, LLC (“Angeles”), a private investment firm focused on value creation through operational transformation, has appointed Brandon Gold as vice president, Operations for Angeles Operations Group, LLC.
  • Angeles is a specialist lower middle-market private equity investment firm with a consistent approach to transforming underperforming industrial businesses.
  • In his role as vice president in Angeles’ affiliated operations group, Gold will support the due diligence process, build and execute value creation plans, and aim to drive the Angeles portfolio companies to their full potential.
  • I am looking forward to leveraging my strategy and operations experience to create value across the Angeles portfolio,” Gold said.

New Hope for Treating Acne Keloidalis Nuchae (AKN) Revealed in Recent Study

Retrieved on: 
Monday, August 28, 2023
Research report, University, Skin, Dermatology, Hope, Woman, American Academy, University of California, Los Angeles, Research, Inflammation, Hair loss, Harbor–UCLA Medical Center, FUE, Journal, Patient, Risk, Report, AKN, Disease, Dietary supplement, Medical device

LOS ANGELES, Aug. 28, 2023 /PRNewswire/ -- Dr. U Hair and Skin Clinic announces a recent research report has illuminated a potential breakthrough in treating Acne Keloidalis Nuchae (AKN), a chronic and burdensome condition.

Key Points: 
  • LOS ANGELES, Aug. 28, 2023 /PRNewswire/ -- Dr. U Hair and Skin Clinic announces a recent research report has illuminated a potential breakthrough in treating Acne Keloidalis Nuchae (AKN), a chronic and burdensome condition.
  • The study titled " Papular Acne Keloidalis Nuchae Treatment Success using Follicular Unit Excision " was published in the Journal of The American Academy of Dermatology – JAAD Case Reports.
  • Our study suggests that FUE could be a promising treatment for AKN, particularly when hair-bearing papules are involved.
  • These findings offer hope to individuals dealing with AKN and healthcare professionals seeking novel strategies to address the condition.

Asia Lab-on-a-Chip and Microfluidics Conference 2023: Agenda to Focus on Life Science Research Applications & Point-of-Care Diagnostic Testing Applications (Tokyo, Japan - October 5-6, 2023)

Retrieved on: 
Thursday, August 3, 2023
University of Southern California, Science, University, University of Kansas, Narita Express, National university, Texas A&M University, Mechanical engineering, Personalized medicine, National University of Singapore, Research, Biomedical engineering, Shinkansen, Japanese cuisine, Chemical substance, University of California, Los Angeles, CNRS, National Football Foundation Distinguished American Award, Translational research, Beer, Coffee, Biological engineering, Travel, University of California, Berkeley, Conference, Lunch, Management, Engineering, Professor, Microfluidics, Medicine

The Lab-on-a-Chip and Microfluidics Asia 2023 Conference will be held on October 5-6, 2023 at the Nikko Naritaright at Tokyo-Narita Airport.This annual event brings together researchers from around the world and across Japan and features academic presentations, industry presentations, an exhibit hall with companies from around the world plus extensive networking opportunities.Travel to Japan is wonderful, convenient, safe and does not require a visa if you hold a US, European or British Passport (visa is stamped upon arrival into Japan). The Nikko Narita provides easy access via Narita Express to Tokyo and then via Shinkansen across Japan.This conference features 4-co-located tracks enabling extensive scientific exchanges and networking across disciplines -- your registration provides access to all conference tracks, all content and all networking events.Lunch is served on both days of the conference in beautiful Japanese bento boxes and features beautifully-prepared Japanese Cuisine. Additionally, the conference includes coffee breaks and a networking reception featuring Japanese Beer and Japanese Sake.In addition to an exhibit hall, the conference also includes poster sessions and encourages attendees to submit posters as a means to showcase their research and engage with the participants.

Key Points: 
  • DUBLIN, Aug. 3, 2023 /PRNewswire/ -- The "Lab-on-a-Chip and Microfluidics Asia 2023" conference has been added to ResearchAndMarkets.com's offering.
  • The Lab-on-a-Chip and Microfluidics Asia 2023 Conference will be held on October 5-6, 2023 at the Nikko Naritaright at Tokyo-Narita Airport.
  • The Nikko Narita provides easy access via Narita Express to Tokyo and then via Shinkansen across Japan.
  • Lunch is served on both days of the conference in beautiful Japanese bento boxes and features beautifully-prepared Japanese Cuisine.

UCLA Student Receives SBB Research Group Foundation STEM Scholarship

Retrieved on: 
Thursday, August 3, 2023
Learning, Tiffany, University, Education, Neurology, Science, technology, engineering, and mathematics, DSM-IV codes, Student, Patent, Patient, STEM, University of California, Los Angeles, Movement disorder, UCLA, Bachelor of Science in Human Biology, Veterinary medicine, Science, Mathematics, Engineering, HAND

CHICAGO, Aug. 2, 2023 /PRNewswire-PRWeb/ -- The SBB Research Group Foundation named Tiffany Chen a recipient of its STEM scholarship. The $2,500 award empowers students to create value for society by pursuing higher learning through interdisciplinary combinations of Science, Technology, Engineering, and Mathematics (STEM).

Key Points: 
  • CHICAGO, Aug. 2, 2023 /PRNewswire-PRWeb/ -- The SBB Research Group Foundation named Tiffany Chen a recipient of its STEM scholarship.
  • The $2,500 award empowers students to create value for society by pursuing higher learning through interdisciplinary combinations of Science, Technology, Engineering, and Mathematics (STEM).
  • "Tiffany's accomplishments are incredible and we can't wait to see what she does next," said Matt Aven, co-founder and board member of the SBB Research Group Foundation.
  • For eligibility criteria and more information on the Foundation's STEM scholarship, please visit http://www.sbbscholarship.org .